Related Experiment Videos
Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization
M Wilson1, J DeRisi, H H Kristensen
1Department of Microbiology, Department of Medicine, Stanford University, Stanford, CA 94305, USA. mike_wilson@affymax.com
Summary
Drug-resistant tuberculosis demands new therapies. Researchers used a DNA microarray to study Mycobacterium tuberculosis gene expression changes in response to isoniazid, identifying key genes for new drug targets.
Area of Science:
- Microbiology
- Genomics
- Drug Discovery
Background:
- Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis.
- Antituberculosis drug resistance is a growing global health concern, necessitating novel therapeutic strategies.
- The complete M. tuberculosis genome sequence enables a genomic approach to understanding TB biology and drug discovery.
Purpose of the Study:
- To investigate changes in M. tuberculosis gene expression in response to the antituberculosis drug isoniazid.
- To identify genes and pathways affected by isoniazid treatment.
- To discover potential new drug targets for tuberculosis treatment.
Main Methods:
- Utilized a DNA microarray containing 97% of predicted M. tuberculosis ORFs.
- Monitored gene expression profiles of M. tuberculosis exposed to isoniazid.
- Analyzed induced genes to understand their physiological relevance and connection to drug action.
Main Results:
- Isoniazid induced genes encoding proteins crucial to its mode of action, including type II fatty acid synthase and trehalose dimycolyl transferase (fbpC).
- Several other genes (efpA, fadE23, fadE24, ahpC) were induced, suggesting involvement in processes linked to drug toxicity.
- The study identified specific gene clusters and enzymes affected by isoniazid.
Conclusions:
- Genomic analysis of gene expression provides insights into the mechanisms of antituberculosis drugs.
- Induced genes like those involved in fatty acid synthesis and drug detoxification represent potential new targets for antituberculosis drug development.
- This approach can guide the discovery of novel compounds to inhibit these targets and combat drug-resistant TB.